Health status and effects of spironolactone in people at high risk of heart failure: The Heart OMics in AGEing (HOMAGE) randomized trial

Introduction and objectives: Maintaining or improving quality of life (QoL) is an important therapeutic goal. QoL may be impaired before clinical onset of heart failure (HF). This study aims to describe changes in health status and the effect of spironolactone in people at risk of developing HF. Met...

Descripció completa

Dades bibliogràfiques

Autors principals:	Inês Aguiar-Neves, Sílvia O. Diaz, João Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, Beatrice Mariottoni, Franco Cosmi, Mark Hazebroek, Job A.J. Verdonschot, Joe Cuthbert, Johannes Petutschnigg, Stephane Heymans, Jan A. Staessen, Burkert Pieske, Frank Edelmann, Andrew L. Clark, Patrick Rossignol, Ricardo Fontes-Carvalho, John G. Cleland, Faiez Zannad
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-05-01
Col·lecció:	Revista Portuguesa de Cardiologia
Matèries:	Estado de saúde Risco de insuficiência cardíaca Espironolactona
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S0870255126000843
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!